Medication therapy management: 10 Years of experience in a large integrated health care system

Journal of Managed Care Pharmacy

Volumn 16, Issue 3, 2010, Pages 185-195

  De Oliveira, Djenane Ramalho ^a   Brummel, Amanda R ^a   Miller, David B ^a  

^a Fairview Pharmacy Services LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMOXICILLIN; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; DRUG;

ADULT; AGED; ALLERGIC RHINITIS; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL ASSESSMENT; COUGHING; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; ESOPHAGITIS; EVIDENCE BASED PRACTICE; FEMALE; HEALTH SERVICE; HEALTH STATUS; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTHYROIDISM; INSOMNIA; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL PRACTICE; MEDICARE; MEDICATION THERAPY MANAGEMENT; MENOPAUSE; NOSE CONGESTION; OCULAR PRURITUS; OSTEOPOROSIS; OTITIS MEDIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; REIMBURSEMENT; RETROSPECTIVE STUDY; RHINORRHEA; STROKE; COST CONTROL; ECONOMICS; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACY; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; COST SAVINGS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PATIENT SATISFACTION; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; PHARMACISTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 77952300830     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.3.185     Document Type: Article

References (50)

1. Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Pub. L. No. 108-173, 117 Stat. 2066 (January 7, 2003). Available at: http://www.cms.hhs.gov/MMAUpdate/downloads/hrl.pdf. Accessed March 16, 2010.
2. Centers for Medicare and Medicaid Services. Medicare Part D medication therapy management (MTM) programs 2009 fact sheet. Updated July 21, 2009. Available at: http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/ MTMFactSheet.pdf. Accessed March 16, 2010.
3. Hassol A, Shoemaker SJ. Exploratory research on medication therapy management: final report. July 8, 2008. Available at: http://www.cms.hhs.gov/ Reports/downloads/Blackwell.pdf. Accessed March 16, 2010.
4. Center for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 7-Medication Therapy Management and Quality Improvement Program. December 1, 2006. Available at: http://www.cms.hhs.gov/ PrescriptionDrugCovContra/Downloads/PDBManual-Chapter7.pdf. Accessed March 16, 2010.
5. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice. New York: McGraw-Hill; 1998:359.
6. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician's Guide. 2nd ed. New York: McGraw-Hill; 2004:394.
7. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-543
8. Hepler CD. The future of pharmacy: pharmaceutical care. Am Pharm. 1990;NS30(10):23-29.
9. Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the Pharmaceutical Care Project in Minnesota. Am Pharm. 1995;NS35(4):30-39.
10. Hepler CD, Strand LM, Tromp D, Sakolchai S. Critically examining pharmaceutical care. J Am Pharm Assoc (Wash). 2002;42(5 Suppl 1):S18-S19.
11. Ramalho de Oliveira D. Pharmaceutical care uncovered: an ethnographic study of pharmaceutical care practice. [dissertation]. Minneapolis, MN: University of Minnesota; 2003.
12. Strand LM, Cipolle RJ, Morley PC, Frakes MJ. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987-4001.
13. McGivney MS, Meyer SM, Duncan-Hewitt W, Hall DL, Goode JV, Smith RB. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003). 2007;47(5):620-628
14. Ramalho de Oliveira D. The Reality of Pharmaceutical Care-Based Medication Therapy Management: Patients', Pharmacists' and Students' Perspectives. Saarbrücken, Germany: Lambert Academic Publishing; 2010:384.
15. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc (2003). 2009;49(2):164-170
16. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43(5):882-889
17. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-725 (Pubitemid 351639999)
18. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757-763
19. Welch EK, Delate T, Chester EA, Stubbings T. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009;43(4):603-610
20. Choe HM, Bernstein SJ, Cooke D, Stutz D, Standiford C. Using a multidisciplinary team and clinical redesign to improve blood pressure control in patients with diabetes. Qual Manag Health Care. 2008;17(3):227-233
21. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421-436
22. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
23. Nietert PJ, Tilley BC, Zhao W, et al. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized controlled trial. Med Care. 2009;47(1):32-40.
24. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: Core elements of an MTM service (version 1.0). J Am Pharm Assoc (2003). 2005;45(5):573-79. Available at: http://www.nacdsfoundation.org/user-assets/ Documents/PDF/MTM%20Model%20final.pdf. Accessed March 17, 2010.
25. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc (2003). 2005;45(5):566-572
26. The Lewin Group. Medication therapy management services: A critical review. J Am Pharm Assoc (2003). 2005;45(5):580-87. Available at: http://www.michiganpharmacists.org/resources/clinicalProjects/ MTM-CriticalReview.pdf. Accessed March 16, 2010.
27. Academy of Managed Care Pharmacy. Sound medication therapy management programs, Version 2.0 with validation study. J Manag Care Pharm. 2008;14(1 Suppl B):S2-S44. Available at: http://www.amcp.org/data/jmcp/JMCPSuppB-Jan08.pdf.
28. American Pharmacists Association, the National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc (2003). 2008;48(3):341-53. Available at: http://www.pharmacist.com/AM/Template.cfm? Section=Home2&CONTENTID=15496&TEMPLATE=/CM/ContentDisplay.cfm. Accessed March 16, 2010.
29. Gonzalez J, Noga M. Medication therapy management. J Manag Care Pharm. 2008;14(6 suppl S-c):8-11. Available at: http://www.amcp.org/data/jmcp/ Aug%20suppl%20C-S8-S11.pdf.
30. Minnesota Senate. Minnesota Senate, S.F. No. 973, 1st Engrossment - 84th Legislative Session (2005-2006). Medication therapy management care. 2005. Available at: https://www.revisor.leg.state.mn.us/bin/bldbill.php?bill=S0973. 1&session=ls84. Accessed March 16, 2010.
31. Isetts BJ. Evaluating effectiveness of the Minnesota Medication Therapy Management Care Program: final report. December 14, 2007. Available at: http://www.dhs.state.mn.us/main/groups/business-partners/documents/pub/ dhs16-140283.pdf. Accessed March 16, 2010.
32. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Int Med. 2003;163(15):1813-1820
33. Isetts BJ, Schondelmeyer SW, Heaton AH, Wadd WB, Hardie NA, Artz MB. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Social Adm Pharm. 2006;2(1):129-142
34. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203-211
35. Thompson CA. State-paid medication therapy management services succeed. Am J Health-Syst Pharm. 2008;65(6):490,493,498.
36. Peters Institute of Pharmaceutical Care. Pharmacotherapy notes. Updated 2008. Available at: http://www.pharmacy.umn.edu/centers/peters/teaching/ pharmacotherapynotes/home.html. Accessed February 26, 2010.
37. Minnesota Community Measurement. The D5: About the D5. 2009. Available at: http://www.thed5.org/index.php?p=about-the-d5. Accessed March 16, 2010.
38. Minnesota Community Measurement, Minnesota Department of Human Services. 2008 Health Care Disparities Report for Minnesota Health Care Programs. 2009. Available at: http://edocs.dhs.state.mn.us/lfserver/Legacy/DHS-5573A-ENG. Accessed March 17, 2010.
39. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27(7):1104-1111 (Pubitemid 41262469)
40. Rao D, Gilbert A, Strand LM, Cipolle RJ. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29(6):647-654 (Pubitemid 47594174)
41. Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents. Am J Cardiol. 2006;98(9):1231-1233 (Pubitemid 44584113)
42. Ansell BJ. Not getting to goal: the clinical costs of noncompliance. J Manag Care Pharm. 2008;14(6 Suppl B):S9-S15. Available at: http://www.amcp.org/ data/jmcp/JMCPSuppB-S9-S15.pdf.
43. Phillips LS, Branch WT, Cook CB, Doyle, J. P. et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-834
44. O'Connor PJ, Sperl-Hillen JAM, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. Advances in Patient Safety. 2005;2:293-308. Available at: http://www.ahrq.gov/downloads/pub/advances/vol2/ OConnor.pdf. Accessed March 16, 2010.
45. Ramalho de Oliveira D, Shoemaker SJ. Achieving patient centeredness in pharmacy practice: openness and the pharmacist's natural attitude. J Am Pharm Assoc (2003). 2006;46(1):56-66.
46. Shoemaker SJ, Ramalho de Oliveira D. Understanding the meaning of medications for patients: the medication experience. Pharm World Sci. 2008;30(1):86-91.
47. Touchette DR, Shapiro NL. Medication compliance, adherence, and persistence: current status of behavioral and educational interventions to improve outcomes. J Manag Care Pharm. 2008;14(6 Suppl D):S2-S10. Available at: http://www.amcp.org/data/jmcp/Aug08%20Suppl%20D-S2-S10.pdf.
48. Stebbins MR, Kaufman DJ, Lipton HL. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services. J Manag Care Pharm. 2005;11(4):333-341. Available at: http://www.amcp.org/data/ jmcp/contemporary-333-341.pdf.
49. Barnett MJ, Frank J, Wehring Hea. Analysis of pharmacy-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15(1):18-31. Available at: http://www.amcp.org/ data/jmcp/018-031.pdf.
50. Benner JS, Kocot SL. Medicare Part D: good for patients and an opportunity for pharmacists. J Manag Care Pharm. 2009;15(1):66-70. Available at: http://www.amcp.org/data/jmcp/066-070.pdf.